Reuters logo
BRIEF-Ose Immunotherapeutics says shareholders approved nominations of two new independent directors
June 14, 2017 / 4:09 PM / 3 months ago

BRIEF-Ose Immunotherapeutics says shareholders approved nominations of two new independent directors

June 14 (Reuters) - Ose Immunotherapeutics Sa

* Ose Immunotherapeutics - all resolutions submitted to a vote at combined general shareholders’ meeting were approved as proposed by Ose Immunotherapeutics’ board

* Ose Immunotherapeutics - shareholders approved nominations of two new independent directors, Brigitte Dréno and Diane Kathryn Jorkasky

* Ordinary General Meeting renewed the board terms of Jean-Patrick Demonsang, Walter Flamenbaum and Gérard Tobelem Source text for Eikon: Further company coverage: (Bengaluru Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below